Newport Biotech Consultants

Dr. Chris Mayhew and technician Amy Pitstick of Cincinnati Children's Hospital

Discussing climate change at University of Cincinnati

Morrow and Mayhew consider stem cell technology at Cincinnati Children's

A visit to Biologic Covington KY

Morrow discussing Bexion technology with Dr. Neil Chaudhary

Discussing protein characterization assays at Bexion

Sinclair College Biotech Advisory Meeting with Dr. Sandra Specht

Sartorius Conference, Gottingen, Germany with Bettina Berendsen, VP sales

with Jason Hayes, Sinclair community College

Performance exceeding expectations.

Newport Biotechnology Consultants serves the life sciences industry providing research, writing, business planning and emergency management solutions.  Founder Dr. K. John Morrow Jr. (President/CEO) draws upon academic and industrial experience to cover new developments and technologies in antibody therapeutics and related areas of biotechnology. With an extensive list of publications in trade and peer-reviewed journals, we are prepared to evaluate business plans, prepare technical reports and develop advertising literature. To download some of my latest publications go to "Who We Are" page.

 

A range of quality services

  • Writing expertise
    • life sciences industry
    • specialization in molecular immunology
  • Coverage of new developments and technologies
  • Emergency management
  • Bio-Safety Consulting
  • Business plan evaluation.
  • Translation, Interpretation   (English/Italian) 
  • Recently coedited with Cheng Liu: "Biosimilars of Monoclonal Antibodies" Wiley Publishers

View all Services

Recent Blog Entries

a bad actor, still unbowed

Lenzilumab and Coronavirus

October 20, 2020

While the search for an effective vaccine against Coronavirus gobbles up most of the public attention in the ongoing battle against Covid19, so-called game changing "breakthroughs" may come from drugs that block the lethal effects of the virus in the generation of "cytokine storms" when the body ...

Read More
*